These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14696769)

  • 21. [Gene mutation and polymorphism as risk factors in the development of hypertensive organ damage].
    Okura T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():92-7. PubMed ID: 15171348
    [No Abstract]   [Full Text] [Related]  

  • 22. Both angiotensinogen M235T and alpha-adducin G460W polymorphisms are associated with hypertension in the Japanese population.
    Nakamura Y; Tabara Y; Miki T; Tamaki S; Kita Y; Okamura T; Ueshima H
    J Hum Hypertens; 2007 Mar; 21(3):253-5. PubMed ID: 17215849
    [No Abstract]   [Full Text] [Related]  

  • 23. The alpha-adducin Gly460Trp polymorphism and the antihypertensive effects of exercise among men with high blood pressure.
    Pescatello LS; Blanchard BE; Tsongalis GJ; Maresh CM; O'Connell A; Thompson PD
    Clin Sci (Lond); 2007 Sep; 113(5):251-8. PubMed ID: 17472579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional alterations of mesenteric small resistance arteries in Milan hypertensive and normotensive rats.
    Rizzoni D; Castellano M; Porteri E; Giacchè M; Ferrari P; Cusi D; De Ciuceis C; Boari GE; Rosei EA
    Hypertens Res; 2009 Jul; 32(7):581-5. PubMed ID: 19407819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All for one and one for all: introduction to a coordinated analysis of the Gly-460-Trp alpha-adducin polymorphism.
    Boerwinkle E;
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):734-5. PubMed ID: 10912761
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach.
    Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G
    Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-erythrocyte cation concentrations in relation to the C1797T beta-adducin polymorphism in a general population.
    Richart T; Thijs L; Kuznetsova T; Tikhonoff V; Zagato L; Lijnen P; Fagard R; Wang J; Bianchi G; Staessen JA
    J Hum Hypertens; 2007 May; 21(5):387-92. PubMed ID: 17301826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of genetic hypotheses in essential hypertension.
    Lalouel JM; Rohrwasser A
    J Hum Genet; 2001; 46(6):299-306. PubMed ID: 11393531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal models of hypertension: an overview.
    Lerman LO; Chade AR; Sica V; Napoli C
    J Lab Clin Med; 2005 Sep; 146(3):160-73. PubMed ID: 16131455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium-lithium countertransport and the Gly460-->Trp alpha-adducin polymorphism in essential hypertension.
    Mead PA; Harvey JN; Rutherford PA; Leitch H; Thomas TH
    Clin Sci (Lond); 2005 Mar; 108(3):231-6. PubMed ID: 15554870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Meckley LM, Veenstra DL. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis. Pharmacogenet Genom 2006; 16:139-147.
    Gerhard T; Beitelshees AL; Johnson JA
    Pharmacogenet Genomics; 2006 Aug; 16(8):613. PubMed ID: 16847430
    [No Abstract]   [Full Text] [Related]  

  • 33. Polymorphism in angiotensin II receptor genes and hypertension.
    Baudin B
    Exp Physiol; 2005 May; 90(3):277-82. PubMed ID: 15640279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genetic dissection of essential hypertension.
    Cowley AW
    Nat Rev Genet; 2006 Nov; 7(11):829-40. PubMed ID: 17033627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Possible interaction of environment and genetic factors in work-related diseases: the case of hypertension].
    Corizzato M; Sega R; Ferrario M; Mancia G; Bianchi C; Fornari C; Perego RA; Cesana G
    Med Lav; 2005; 96(6):467-82. PubMed ID: 16983972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geneticism of essential hypertension.
    Luft FC
    Hypertension; 2004 Jun; 43(6):1155-9. PubMed ID: 15117914
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of hypertension-related genes through an integrated genomic-transcriptomic approach.
    Yagil C; Hubner N; Monti J; Schulz H; Sapojnikov M; Luft FC; Ganten D; Yagil Y
    Circ Res; 2005 Apr; 96(6):617-25. PubMed ID: 15731461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of alpha-adducin Gly460Trp polymorphism with coronary artery disease in a Korean population.
    Cha SH; Kim HT; Jang Y; Park S; Kim JJ; Song MY; Park JH; Ryu HJ; Park HY; Yoon SJ; Kimm K; Lee JK; Oh B
    J Hypertens; 2007 Dec; 25(12):2413-20. PubMed ID: 17984662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined analysis of polymorphisms in angiotensinogen and adducin genes and their effects on hypertension in a Japanese sample: The Shigaraki Study.
    Tamaki S; Nakamura Y; Tabara Y; Okamura T; Kita Y; Kadowaki T; Tsujita Y; Horie M; Miki T; Ueshima H
    Hypertens Res; 2005 Aug; 28(8):645-50. PubMed ID: 16392768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adducin and hypertension].
    Tian QP; Gao W; Chen GH
    Sheng Li Ke Xue Jin Zhan; 1998 Apr; 29(2):169-70. PubMed ID: 12501690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.